StreetAccount Summary: EU stocks reaching new 52-week highs/lows (65 total)
Gerresheimer downgraded to hold from buy at Hauck & Aufhäuser (€27.50, 0.00)
Gerresheimer downgraded to equal weight from overweight at Barclays (€27.50, 0.00)
StreetAccount Summary - Trading higher/lower: EU mid-morning
Gerresheimer downgraded to neutral from buy at UBS (€28.68, 0.00)
Gerresheimer announces FDA grants approval of SQ Innovation's Lasix ONYU (€29.08, +0.32)
Transcript Intelligence: Gerresheimer Q3 Earnings Guidance (€29.98, -0.56)
Transcript Intelligence: Gerresheimer Q3 Earnings Themes (€29.98, -0.56)
Transcript Intelligence: Gerresheimer Q3 Earnings Q&A (€29.98, -0.56)
Powered by FactSet Research Systems Inc.